Targeting the Transforming Growth Factor-β pathway inhibits human basal-like breast cancer metastasis

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1476-4598

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Targeting the Transforming Growth Factor-β pathway inhibits human basal-like breast cancer metastasis ; volume:9 ; number:1 ; day:26 ; month:5 ; year:2010 ; pages:1-16 ; date:12.2010
Molecular cancer ; 9, Heft 1 (26.5.2010), 1-16, 12.2010

Creator: Ganapathy, Vidya
Ge, Rongrong
Grazioli, Alison
Xie, Wen
Banach-Petrosky, Whitney
Kang, Yibin
Lonning, Scott
McPherson, John
Yingling, Jonathan M.
Biswas, Swati
Mundy, Gregory R.
Reiss, Michael

Contributor: SpringerLink (Online service)

DOI: 10.1186/1476-4598-9-122

URN: urn:nbn:de:101:1-2021082720024794598755

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:59 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Ganapathy, Vidya
Ge, Rongrong
Grazioli, Alison
Xie, Wen
Banach-Petrosky, Whitney
Kang, Yibin
Lonning, Scott
McPherson, John
Yingling, Jonathan M.
Biswas, Swati
Mundy, Gregory R.
Reiss, Michael
SpringerLink (Online service)

Other Objects (12)

BRD4-specific PROTAC inhibits basal-like breast cancer partially through downregulating KLF5 expression

FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer

Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype

Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival

Inactivation of LATS1/2 drives luminal-basal plasticity to initiate basal-like mammary carcinomas

Weight loss reduces basal-like breast cancer through kinome reprogramming

1,1-Bis(3'-indolyl)-1-(p-biphenyl)methane inhibits basal-like breast cancer growth in athymic nude mice

Basal-like breast cancer: molecular profiles, clinical features and survival outcomes

Targeting BCL-2–expressing basal-like breast cancer with BH3-mimetics

The CD44+/CD24-phenotype is enriched in basal-like breast tumors

Activation of Bivalent Gene POU4F1 Promotes and Maintains Basal‐like Breast Cancer

Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer

BRD4-specific PROTAC inhibits basal-like breast cancer partially through downregulating KLF5 expression

FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer

Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype

Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival

Inactivation of LATS1/2 drives luminal-basal plasticity to initiate basal-like mammary carcinomas

Weight loss reduces basal-like breast cancer through kinome reprogramming

1,1-Bis(3'-indolyl)-1-(p-biphenyl)methane inhibits basal-like breast cancer growth in athymic nude mice

Basal-like breast cancer: molecular profiles, clinical features and survival outcomes

Targeting BCL-2–expressing basal-like breast cancer with BH3-mimetics

The CD44+/CD24-phenotype is enriched in basal-like breast tumors

Activation of Bivalent Gene POU4F1 Promotes and Maintains Basal‐like Breast Cancer

Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer

BRD4-specific PROTAC inhibits basal-like breast cancer partially through downregulating KLF5 expression

FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer

Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype

Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival

Inactivation of LATS1/2 drives luminal-basal plasticity to initiate basal-like mammary carcinomas

Weight loss reduces basal-like breast cancer through kinome reprogramming

1,1-Bis(3'-indolyl)-1-(p-biphenyl)methane inhibits basal-like breast cancer growth in athymic nude mice

Basal-like breast cancer: molecular profiles, clinical features and survival outcomes

Targeting BCL-2–expressing basal-like breast cancer with BH3-mimetics

The CD44+/CD24-phenotype is enriched in basal-like breast tumors

Activation of Bivalent Gene POU4F1 Promotes and Maintains Basal‐like Breast Cancer

Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read and agree to the privacy policy for the collection of personal data.*

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Targeting the Transforming Growth Factor-β pathway inhibits human basal-like breast cancer metastasis

Show object

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

BRD4-specific PROTAC inhibits basal-like breast cancer partially through downregulating KLF5 expression

FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer

Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype

Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival

Inactivation of LATS1/2 drives luminal-basal plasticity to initiate basal-like mammary carcinomas

Weight loss reduces basal-like breast cancer through kinome reprogramming

1,1-Bis(3'-indolyl)-1-(p-biphenyl)methane inhibits basal-like breast cancer growth in athymic nude mice

Basal-like breast cancer: molecular profiles, clinical features and survival outcomes

Targeting BCL-2–expressing basal-like breast cancer with BH3-mimetics

The CD44+/CD24-phenotype is enriched in basal-like breast tumors

Activation of Bivalent Gene POU4F1 Promotes and Maintains Basal‐like Breast Cancer

Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer

BRD4-specific PROTAC inhibits basal-like breast cancer partially through downregulating KLF5 expression

FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer

Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype

Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival

Inactivation of LATS1/2 drives luminal-basal plasticity to initiate basal-like mammary carcinomas

Weight loss reduces basal-like breast cancer through kinome reprogramming

1,1-Bis(3'-indolyl)-1-(p-biphenyl)methane inhibits basal-like breast cancer growth in athymic nude mice

Basal-like breast cancer: molecular profiles, clinical features and survival outcomes

Targeting BCL-2–expressing basal-like breast cancer with BH3-mimetics

The CD44+/CD24-phenotype is enriched in basal-like breast tumors

Activation of Bivalent Gene POU4F1 Promotes and Maintains Basal‐like Breast Cancer

Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer

BRD4-specific PROTAC inhibits basal-like breast cancer partially through downregulating KLF5 expression

FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer

Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype

Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival

Inactivation of LATS1/2 drives luminal-basal plasticity to initiate basal-like mammary carcinomas

Weight loss reduces basal-like breast cancer through kinome reprogramming

1,1-Bis(3'-indolyl)-1-(p-biphenyl)methane inhibits basal-like breast cancer growth in athymic nude mice

Basal-like breast cancer: molecular profiles, clinical features and survival outcomes

Targeting BCL-2–expressing basal-like breast cancer with BH3-mimetics

The CD44+/CD24-phenotype is enriched in basal-like breast tumors

Activation of Bivalent Gene POU4F1 Promotes and Maintains Basal‐like Breast Cancer

Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer

Related objects

Reset password